Carl N. Kraus, Chief Officer of Aquestive Therapeutics AQST, has filed 0 purchases and 1 sale on the open market. Over the past 12 months that comes to a net sale of $141.9K. The latest trade was on 25/10/15.

CK

CK

Carl N. Kraus

Chief Medical Officer

Company

Aquestive Therapeutics AQST

First filing

23/01/19

Trades

11 trades

Buys / sales

0 / 1

12-month net buying

−$141.9K

Last trade

25/10/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aquestive TherapeuticsAQST	Open-market sale10b5-1 plan	25/10/15	25/10/17	20,272 sh	$7.00	$141,904	−6.7%